PolarityTE Inc. (PTE) |
|
1.03 -0.01 (-0.96%)
|
10-01 15:00 |
|
Open: |
1.05 |
Pre. Close: |
1.04 |
|
High:
|
1.07 |
Low:
|
1.02 |
|
Volume:
|
75,307 |
Market Cap:
|
40M |
|
|
|
|
PolarityTE, Inc. is a biotechnology company developing and commercializing regenerative tissue products and biomaterials. The company is headquartered in Salt Lake City, Utah and currently employs 156 full-time employees. The firm seeks to develop and obtain regulatory approval for technology that will utilize a patient's own tissue substrates for the regeneration of skin, bone, muscle, cartilage, fat, blood vessels and nerves. The firm's PolarityTE platform simplifies regeneration and allows cells to function naturally. The platform can be applied across all cells, tissues and composite structures. The firm focuses on various products, including SkinTE, OsteoTE, AngioTE, MyoTE, CartTE, AdiposeTE and NeuralTE. The Company, through SkinTE, is focused on supplying an autologous construct to regenerate a patient’s skin due to a variety of injuries and conditions. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
1.071 - 1.075 |
1.075 - 1.078 |
|
Low:
|
1 - 1.004 |
1.004 - 1.008 |
|
Close:
|
1.033 - 1.04 |
1.04 - 1.046 |
|
Technical analysis |
as of: 2020-10-01 2:38:27 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 1.35 One year: 1.48 |
| Support: |
Support1: 0.97 Support2: 0.81 |
| Resistance: |
Resistance1: 1.16 Resistance2: 1.27 |
| Pivot: |
1.04 |
| Moving Average: |
MA(5): 1.03  MA(20): 1.06
MA(100): 1.25 MA(250): 1.84 |
| MACD: |
MACD(12,26): -0.06 Signal(9): -0.07 |
| Stochastic oscillator: |
%K(14,3): 30.92 %D(3): 27.64 |
| RSI: |
RSI(14): 40.38 |
| 52-week: |
High: 4.60 Low: 0.78 Change(%): -66.6 |
| Average Vol(K): |
3-Month: 118985 10-Days: 21176 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.PTE has closed above bottom band by 32.3%. Bollinger Bands are 72% narrower than normal. The narrow width of the bands suggests low volatility as compared to PTE's normal range. The bands have been in this narrow range for 9 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Tue, 29 Sep 2020
PolarityTE Announces Termination of Shareholder Rights Plan - Business Wire
Mon, 21 Sep 2020
PolarityTE Receives NIH Grant for a Point-of-Care Device to Treat Chronic Wounds - Valdosta Daily Times
Wed, 16 Sep 2020
SkinTE™ Health Economics—DFU Interim Analysis Data Demonstrates Potential for Cost Savings and Improved Wound Closure - Yahoo Finance
Mon, 14 Sep 2020
PolarityTE Expects Third Quarter Revenue to Meet or Exceed High-End of Guidance - Business Wire
Thu, 10 Sep 2020
PolarityTE to Present at H.C. Wainwright 22nd Annual Global Investment Conference and Cantor Virtual Global Healthcare Conference - Yahoo Finance
Wed, 09 Sep 2020
PolarityTE, Inc. (NASDAQ:PTE) Is Up 13.46% – Is It Capable of A Rally? - Stocks Register
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Underperform |
Price to Earnings: |
Underperform |
| Return on Equity: |
Underperform |
Debt to Equity: |
Outperform |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
39 |
| Shares Float (M) |
22 |
|
% Held by Insiders
|
39.24 |
|
% Held by Institutions
|
22.50 |
|
Shares Short (K)
|
2,820 |
|
Shares Short P. Month (K)
|
3,360 |
Stock Financials |
|
EPS
|
-2.236 |
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
0.870 |
|
Profit Margin
|
|
|
Operating Margin
|
-1106.48 |
|
Return on Assets (ttm)
|
-60.7 |
|
Return on Equity (ttm)
|
-139.8 |
|
Qtrly Rev. Growth
|
70.9 |
|
Gross Profit (p.s.)
|
0.082 |
|
Sales Per Share
|
0.156 |
|
EBITDA (p.s.)
|
-1.646 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-53 |
|
Levered Free Cash Flow (M)
|
-26 |
Stock Valuations |
|
PE Ratio
|
-0.46 |
|
PEG Ratio
|
|
|
Price to Book value
|
1.18 |
|
Price to Sales
|
6.54 |
|
Price to Cash Flow
|
-0.74 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
2016-01-14 |
|
Ex-Dividend Date
|
2016-01-11 |
|
7 Binary Options
|
|
Your Ad Here
|
|
